No Data
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
6 analysts have shared their evaluations of ADMA Biologics (NASDAQ:ADMA) during the recent three months, expressing a mix of bullish and bearish perspectives.The following table provides a quick overv
ADMA Biologics Is Maintained at Buy by Mizuho
ADMA Biologics Is Maintained at Buy by Mizuho
ADMA Biologics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/20/2024 31.71% Mizuho $12 → $14 Maintains Buy 05/10/2024 -5.92% Raymond James $8 → $10 Maintains Strong
Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Raises Target Price to $14
Mizuho Securities analyst Anthony Petrone maintains $ADMA Biologics(ADMA.US)$ with a buy rating, and adjusts the target price from $12 to $14.According to TipRanks data, the analyst has a success rate
Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $14 From $12